Mindray Medical makes a big investment of 4.5 billion in this equipment market

This equipment market, Murray Medical is also movingNO.1 Invests 4.5 billion, Meirui Medical Big Action June 22, according to Changjiang Daily News, Meirui Medical's second global headquarters has been opened in WuhanMeirui Medical announced that the total investment of the Wuhan production base project and the Wuhan Research Institute project is not expected to exceed 4.5 billion yuan, the former is expected to have a total investment of 2 billion yuan, and the total investment of the latter is not expected to exceed 2.5 billion yuanAt the same time, Meirui Medical also signed an agreement with the Wuhan East Lake New Technology Development Zone Management Committee, committed to the effective period of 5 years from the effective date of the agreement, Wuhan production base project company output value reached 3 billion yuan, the cumulative production of enterprise income tax, value-added tax reached 108 million yuan, the introduction of 2000 personnelMeirui Medical also promised that within five years from the effective date of this agreement, Wuhan Research Institute Project Company employees reached 2000, of which the project company research and development personnel reached 1,200Project company has obtained no less than 100 patent certificates and medical device registration certificates related to medical biomaterials and equipmentIt is worth noting that the construction of Meirui Medical Wuhan production base includes orthopaedic implants and surgical treatment equipment manufacturing, testing reagents manufacturing, bio-raw material preparation, minimally invasive surgical equipment manufacturingThis is not the first time Murray Medical has mentioned entering the field of minimally invasive surgical equipmentOn July 11, 2019, Myer Medical announced its 2019 half-year results forecast that it had invested in endoscopic surgical instruments and hard mirror systems, and that some technical accumulation would foster new business growth pointsOn April 2 this year, Murray Medical released its 2019 annual report, saying that in addition to the three major product areas, the company is actively developing minimally invasive surgical business, including surgical cavity camera systems, cold light sources, air abdominal machines, optical endoscopes, minimally invasive surgical instruments and surgical suppliesNO.2 Industries with gross margins of more than 80% On June 28, 2019, Hangzhou Kangji Medical Devices Co., Ltdissued a prospectus to declare the listing of the Main Board of the Shanghai Stock ExchangeAccording to the prospectus, the gross margin of Kangji Medical was 79.26%, 81.50% and 82.43% respectively in 2016-18, and has been on an upward trend of around 80%Kangji Medical is engaged in endoscopic minimally invasive surgery medical device-related business, the main products are disposable minimally invasive surgical medical devices and repetitive minimally invasive surgical medical devices, including one-time puncture perm, disposable ligation clips, disposable clamps, repetitive pliers and repetitive puncturepersMyer's entry into minimally invasive surgical equipment may be related to the high gross margin of the product and the rapid growth of the segmented industryIt is understood that endoscopy minimally invasive surgery is through a small hole or micro-incision for the removal of organ lesions, malformation correction, repair or reconstruction of various surgical procedures, and ultimately achieve therapeutic purposesCompared with traditional surgery, minimally invasive surgery has the advantages of small surgical vent area, low blood loss and rapid recovery after surgery, and many traditional body table cutting surgery has been gradually replaced by endoscopy minimally invasive surgery, which has become one of the fastest developing fields in the domestic medical device industry in recent years Minimally invasive surgical instruments mainly include endoscopes, puncturepers and so on China Medical Device Industry Association data show that China's domestic eyeglass market growth is rapid, in 2011 china's domestic scope market size of 6.747 billion yuan, to 2018 vothole market size reached 27.8 billion yuan Endoscopy minimally invasive surgical equipment market size remains at about 2 times the market size of the endoscope market, in 2011, its market size reached 13.494 billion yuan, in 2018 to 55 billion yuan For puncturers, in 2016, 2017 and 2018, China's puncture periscope market size is 4.29 billion yuan, 5.45 billion yuan, 6.43 billion yuan, and by 2021, china's punctureper market size is expected to reach 10.3 billion yuan NO.3 Domestic substitution space is huge Murray Medical said in its annual report that in a small number of subsectors have completed import substitution, the rate of localization of more than 60%, in some subsectors have completed technological breakthroughs, but has not yet replaced imported products But in a considerable number of sub-areas, there is no master of the core technology, such as ultra-high-end color super, endoscopes and so on Overall, China's high-end medical device market is still mainly imported brands, import substitution still has a long way to go Similarly, China's minimally invasive surgical instruments market is growing rapidly, but the main market is still the import of multinational arms companies Kangji Medical also said in the prospectus, endoscopy minimally invasive surgical instruments industry is mainly driven by the development of medical technology level, due to the late development of domestic endoscopy minimally invasive surgery, so the industrialization process of the industry as a whole lags behind developed countries, in China is still a new industry The United States, Japan, Germany and other developed countries in the world's leading level of medical technology, including endoscopy minimally invasive surgical instruments with its advanced processing capacity and technology level, access to the international range of brand influence The international lysing manufacturers of endoscope minimally invasive surgical instruments, represented by Medtronic, Johnson and Johnson, Olympus of Japan, and Karlstos of Germany, occupy the leading position of endoscope minimally invasive surgical instruments globally, and also occupy the main share of China's market According to China Industrial Information Network data, endoscope technical barriers are high, the market concentration is high, especially soft endoscopes, Japanese enterprises with CCD image sensor technology in the world to form a monopoly, industry giant Olympus city accounted for 65% Hard endoscopes are dominated by German and Japanese companies The market share of domestic endoscopes is very low, the proportion of sales is estimated at about 20%, there is a huge space for import substitution Original title: This equipment market, Murray on the look.